Narrowband IoT
Narrowband IoT market is segmented by players, region (country), by Type and by Application. Play ... Read More
Global Narcolepsy Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Daytime Extreme Sleepiness
1.2.3 Cataplexia
1.2.4 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Market Perspective (2017-2028)
2.2 Narcolepsy Growth Trends by Region
2.2.1 Narcolepsy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Narcolepsy Historic Market Size by Region (2017-2022)
2.2.3 Narcolepsy Forecasted Market Size by Region (2023-2028)
2.3 Narcolepsy Market Dynamics
2.3.1 Narcolepsy Industry Trends
2.3.2 Narcolepsy Market Drivers
2.3.3 Narcolepsy Market Challenges
2.3.4 Narcolepsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Players by Revenue
3.1.1 Global Top Narcolepsy Players by Revenue (2017-2022)
3.1.2 Global Narcolepsy Revenue Market Share by Players (2017-2022)
3.2 Global Narcolepsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Narcolepsy Revenue
3.4 Global Narcolepsy Market Concentration Ratio
3.4.1 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Revenue in 2021
3.5 Narcolepsy Key Players Head office and Area Served
3.6 Key Players Narcolepsy Product Solution and Service
3.7 Date of Enter into Narcolepsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Breakdown Data by Type
4.1 Global Narcolepsy Historic Market Size by Type (2017-2022)
4.2 Global Narcolepsy Forecasted Market Size by Type (2023-2028)
5 Narcolepsy Breakdown Data by Application
5.1 Global Narcolepsy Historic Market Size by Application (2017-2022)
5.2 Global Narcolepsy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Narcolepsy Market Size (2017-2028)
6.2 North America Narcolepsy Market Size by Country (2017-2022)
6.3 North America Narcolepsy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Narcolepsy Market Size (2017-2028)
7.2 Europe Narcolepsy Market Size by Country (2017-2022)
7.3 Europe Narcolepsy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Market Size (2017-2028)
8.2 Asia-Pacific Narcolepsy Market Size by Country (2017-2022)
8.3 Asia-Pacific Narcolepsy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Narcolepsy Market Size (2017-2028)
9.2 Latin America Narcolepsy Market Size by Country (2017-2022)
9.3 Latin America Narcolepsy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Market Size (2017-2028)
10.2 Middle East & Africa Narcolepsy Market Size by Country (2017-2022)
10.3 Middle East & Africa Narcolepsy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Detail
11.1.2 Jazz Pharmaceuticals Business Overview
11.1.3 Jazz Pharmaceuticals Narcolepsy Introduction
11.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2017-2022)
11.1.5 Jazz Pharmaceuticals Recent Development
11.2 Bioprojet
11.2.1 Bioprojet Company Detail
11.2.2 Bioprojet Business Overview
11.2.3 Bioprojet Narcolepsy Introduction
11.2.4 Bioprojet Revenue in Narcolepsy Business (2017-2022)
11.2.5 Bioprojet Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Detail
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Narcolepsy Introduction
11.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2017-2022)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Graymark Healthcare
11.4.1 Graymark Healthcare Company Detail
11.4.2 Graymark Healthcare Business Overview
11.4.3 Graymark Healthcare Narcolepsy Introduction
11.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2017-2022)
11.4.5 Graymark Healthcare Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Narcolepsy Introduction
11.5.4 Mylan Revenue in Narcolepsy Business (2017-2022)
11.5.5 Mylan Recent Development
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Detail
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Narcolepsy Introduction
11.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2017-2022)
11.6.5 Teva Pharmaceutical Industries Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Narcolepsy Introduction
11.7.4 Novartis Revenue in Narcolepsy Business (2017-2022)
11.7.5 Novartis Recent Development
11.8 Takeda
11.8.1 Takeda Company Detail
11.8.2 Takeda Business Overview
11.8.3 Takeda Narcolepsy Introduction
11.8.4 Takeda Revenue in Narcolepsy Business (2017-2022)
11.8.5 Takeda Recent Development
11.9 Shionogi
11.9.1 Shionogi Company Detail
11.9.2 Shionogi Business Overview
11.9.3 Shionogi Narcolepsy Introduction
11.9.4 Shionogi Revenue in Narcolepsy Business (2017-2022)
11.9.5 Shionogi Recent Development
11.10 Ligand Pharmaceuticals
11.10.1 Ligand Pharmaceuticals Company Detail
11.10.2 Ligand Pharmaceuticals Business Overview
11.10.3 Ligand Pharmaceuticals Narcolepsy Introduction
11.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2017-2022)
11.10.5 Ligand Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Narcolepsy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Daytime Extreme Sleepiness
Table 3. Key Players of Cataplexia
Table 4. Key Players of Others
Table 5. Global Narcolepsy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Narcolepsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Narcolepsy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Narcolepsy Market Share by Region (2017-2022)
Table 9. Global Narcolepsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Narcolepsy Market Share by Region (2023-2028)
Table 11. Narcolepsy Market Trends
Table 12. Narcolepsy Market Drivers
Table 13. Narcolepsy Market Challenges
Table 14. Narcolepsy Market Restraints
Table 15. Global Narcolepsy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Narcolepsy Market Share by Players (2017-2022)
Table 17. Global Top Narcolepsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy as of 2021)
Table 18. Ranking of Global Top Narcolepsy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Narcolepsy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Narcolepsy Product Solution and Service
Table 22. Date of Enter into Narcolepsy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Narcolepsy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Narcolepsy Revenue Market Share by Type (2017-2022)
Table 26. Global Narcolepsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Narcolepsy Revenue Market Share by Type (2023-2028)
Table 28. Global Narcolepsy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Narcolepsy Revenue Market Share by Application (2017-2022)
Table 30. Global Narcolepsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Narcolepsy Revenue Market Share by Application (2023-2028)
Table 32. North America Narcolepsy Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Narcolepsy Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Narcolepsy Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Narcolepsy Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Narcolepsy Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Narcolepsy Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Narcolepsy Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Narcolepsy Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Narcolepsy Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Narcolepsy Market Size by Country (2023-2028) & (US$ Million)
Table 42. Jazz Pharmaceuticals Company Detail
Table 43. Jazz Pharmaceuticals Business Overview
Table 44. Jazz Pharmaceuticals Narcolepsy Product
Table 45. Jazz Pharmaceuticals Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 46. Jazz Pharmaceuticals Recent Development
Table 47. Bioprojet Company Detail
Table 48. Bioprojet Business Overview
Table 49. Bioprojet Narcolepsy Product
Table 50. Bioprojet Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 51. Bioprojet Recent Development
Table 52. Arena Pharmaceuticals Company Detail
Table 53. Arena Pharmaceuticals Business Overview
Table 54. Arena Pharmaceuticals Narcolepsy Product
Table 55. Arena Pharmaceuticals Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 56. Arena Pharmaceuticals Recent Development
Table 57. Graymark Healthcare Company Detail
Table 58. Graymark Healthcare Business Overview
Table 59. Graymark Healthcare Narcolepsy Product
Table 60. Graymark Healthcare Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 61. Graymark Healthcare Recent Development
Table 62. Mylan Company Detail
Table 63. Mylan Business Overview
Table 64. Mylan Narcolepsy Product
Table 65. Mylan Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 66. Mylan Recent Development
Table 67. Teva Pharmaceutical Industries Company Detail
Table 68. Teva Pharmaceutical Industries Business Overview
Table 69. Teva Pharmaceutical Industries Narcolepsy Product
Table 70. Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 71. Teva Pharmaceutical Industries Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Narcolepsy Product
Table 75. Novartis Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Takeda Company Detail
Table 78. Takeda Business Overview
Table 79. Takeda Narcolepsy Product
Table 80. Takeda Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 81. Takeda Recent Development
Table 82. Shionogi Company Detail
Table 83. Shionogi Business Overview
Table 84. Shionogi Narcolepsy Product
Table 85. Shionogi Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 86. Shionogi Recent Development
Table 87. Ligand Pharmaceuticals Company Detail
Table 88. Ligand Pharmaceuticals Business Overview
Table 89. Ligand Pharmaceuticals Narcolepsy Product
Table 90. Ligand Pharmaceuticals Revenue in Narcolepsy Business (2017-2022) & (US$ Million)
Table 91. Ligand Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Market Share by Type: 2021 VS 2028
Figure 2. Daytime Extreme Sleepiness Features
Figure 3. Cataplexia Features
Figure 4. Others Features
Figure 5. Global Narcolepsy Market Share by Application in 2021 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Narcolepsy Report Years Considered
Figure 10. Global Narcolepsy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Narcolepsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Narcolepsy Market Share by Region: 2021 VS 2028
Figure 13. Global Narcolepsy Market Share by Players in 2021
Figure 14. Global Top Narcolepsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Narcolepsy Revenue in 2021
Figure 16. North America Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Narcolepsy Market Share by Country (2017-2028)
Figure 18. United States Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Narcolepsy Market Share by Country (2017-2028)
Figure 22. Germany Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Narcolepsy Market Share by Region (2017-2028)
Figure 30. China Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Narcolepsy Market Share by Country (2017-2028)
Figure 38. Mexico Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Narcolepsy Market Share by Country (2017-2028)
Figure 42. Turkey Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Narcolepsy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Jazz Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 45. Bioprojet Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 46. Arena Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 47. Graymark Healthcare Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 48. Mylan Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 49. Teva Pharmaceutical Industries Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 50. Novartis Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 51. Takeda Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 52. Shionogi Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 53. Ligand Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Jazz Pharmaceuticals Bioprojet Arena Pharmaceuticals Graymark Healthcare Mylan Teva Pharmaceutical Industries Novartis Takeda Shionogi Ligand Pharmaceuticals